NPPB and congestive heart failure: Clinical research has demonstrated that QSG is superior to placebo in decreasing NT-proBNP in CHF patients and enhancing the quality of life, the 6-min walk test (6MWD), the NYHA cardiac function grade, and the symptom score scale (Du et al., 2022).